Sie sind auf Seite 1von 3

NOTES

NOTES
ADRENAL HYPERPLASIA

CONGENITAL ADRENAL
HYPERPLASIA
osms.it/congenital-adrenal-hyperplasia
11-beta-hydroxylase deficiency
PATHOLOGY & CAUSES ▪ Defective gene: CYP11B1
▪ 7% of CAH cases
▪ Congenital adrenal hyperplasia (CAH) is a
group of autosomal-recessive metabolic ▪ Lack of enzyme prevents conversion of
disorders characterized by defects in 11-deoxycortisol to cortisol
certain genes resulting in a partial/total lack ▪ 11-deoxycortisol (aldosterone precursor)
of an enzyme involved in steroidogenesis has mild mineralocorticoid effect →
within the adrenal cortex biphasic effect on mineralocorticoid balance
▫ ↓ steroid hormone production →
compensatory ↑ ACTH → adrenal
hyperplasia SIGNS & SYMPTOMS
▫ ↓ cortisol → cortisol precursor
accumulation → steroid precursors 21-hydroxylase deficiency
shunted to overproduction of other ▪ Varies by subtype
ACTH-dependent adrenal steroids
17-alpha hydroxylase deficiency
▪ ↓ cortisol → corticosterone presence
TYPES prevents adrenal crisis
21-hydroxylase deficiency ▪ Mineralocorticoid excess → secondary
hypertension; hypokalemic alkalosis
▪ Defective gene: CYP21A2
▪ Gonadocorticoid deficiency (males:
▪ Most common type of CAH
mildly underdeveloped genitalia,
▫ Classic: neonatal/early infancy hypergonadotropic hypogonadism; females:
genital ambiguity in females, adrenal abnormal pubertal sexual development,
insufficiency; classic non-salt-losing infertility)
(simple virilizing): female fetus
virilization; classic salt-losing 11-beta-hydroxylase deficiency
▫ Non-classic (late onset): presents later ▪ Androgen excess → external genitalia
in life (child-adult) with androgen excess virilization, sexual ambiguity (females)
signs; non-salt-losing ▪ Biphasic mineralocorticoid balance →
possible salt-wasting crisis in early infancy;
17-alpha hydroxylase deficiency
secondary hypertension and hypokalemia
▪ Defective gene: CYP17A1 in childhood and adult life
▪ Rare
▪ Steroid precursors for testosterone, cortisol
synthesis shunted to aldosterone

OSMOSIS.ORG 73
TREATMENT
MEDICATIONS
▪ 21-hydroxylase deficiency
▫ Exogenous glucocorticoid
(hydrocortisone), mineralocorticoid
(fludrocortisone)
▪ 11-beta-hydroxylase deficiency
▫ Exogenous glucocorticoid
(hydrocortisone), antihypertensives
▪ 17-alpha hydroxylase deficiency
Figure 12.1 Clitoromegaly with normal labia
and introitus in a biologically female individual ▫ Exogenous glucocorticoid
with 21-hydroxylase deficiency. (hydrocortisone), sex steroid
replacement beginning at puberty,
antihypertensives
▪ If CAH diagnosed prenatally
DIAGNOSIS ▫ Dexamethasone

▪ Clinical presentation
SURGERY
▫ Steroid imbalance evidence
▪ Potential atypical genitalia correction
▪ Most cases identified via newborn
screening
OTHER INTERVENTIONS
LAB RESULTS ▪ Address complications (e.g., fluid,
electrolyte imbalance)
Serum hormone levels ▪ Monitor
▪ 21-hydroxylase deficiency ▫ Serum 17-hydroxyprogesterone, renin,
▫ ↓ sodium (salt-losing type), ↑ potassium electrolytes
(salt-losing type) ▫ Blood pressure
▫ Serum markers: ↑↑ serum ▫ Bone age and density
17-hydroxyprogesterone, ↑ ▫ Tanner staging
21-deoxycortisol) ▫ Weight
▪ 17-alpha hydroxylase deficiency ▫ Growth velocity
▫ ↑ sodium, ↓ potassium
▫ Serum markers: ↑ pregnenolone, ↑
progesterone, ↑ 11-deoxycorticosterone,
↑ 11-deoxycortisol
▪ 11-beta-hydroxylase deficiency
▫ ↑ sodium, ↓ potassium
▫ Serum markers: ↑
11-deoxycorticosterone, ↑
11-deoxycortisol)

Genetic testing

Prenatal diagnosis
▪ By chorionic villus sampling at 10–12
weeks

74 OSMOSIS.ORG
Chapter 12 Adrenal Hyperplasia

OSMOSIS.ORG 75

Das könnte Ihnen auch gefallen